申请人:EISAI R&D MAN CO LTD
公开号:WO2017066633A1
公开(公告)日:2017-04-20
We provide compounds given by Formula I, which is shown in FIG. 3, or pharmaceutically acceptable salts thereof, as well as formulations thereof and methods of use of those compounds and formulations for treatment of cancer.